Literature DB >> 31201493

Prognostic value of N1c in colorectal cancer: a large population-based study using propensity score matching.

Feng Shen1, Xia Hong2.   

Abstract

PURPOSE: We conducted this large population-based study to investigate the prognostic significance of N1c.
METHODS: Patients diagnosed with colorectal cancer from the surveillance, epidemiology, and end results (SEER) database between January 1, 2010, and December 31, 2010, were included in the sample. The primary outcome of interest used in our study was cause-specific survival (CSS). Cox proportional hazards models and Kaplan-Meier methods were used to evaluate the prognostic value of N1c. Propensity score matching (PSM) was implemented to reduce the possibility of selection bias using a logistic regression model.
RESULTS: A total of 19,991 patients diagnosed with colorectal cancer were identified from the SEER database. The median follow-up time of the whole cohort was 60 months (0-71 months). Multivariate Cox analysis showed that N1c was associated with significantly higher risk of colorectal cancer-specific mortality compared with N0 (HR = 1.962, 95%CI = 1.642 to 2.343, P < 0.001) and N1a (HR = 0.818, 95%CI = 0.678 to 0.987, P = 0.036); N1c was associated with significantly lower risk of colorectal cancer-specific mortality compared with N2a (HR = 1.296, 95%CI = 1.081 to 1.554, P = 0.005) and N2b (HR = 1.663, 95%CI = 1.391 to 1.989, P < 0.001). Yet the CSS difference between N1b and N1c did not achieve statistical difference (HR = 1.089, 95%CI = 0.909 to 1.304, P = 0.354).
CONCLUSIONS: The large population-based and propensity score-matched study with long follow-up time provides the first evidence that CSS difference between N1b and N1c does not achieve a statistical difference.

Entities:  

Keywords:  Colorectal cancer; N1c; Propensity score-matched; Tumor deposit

Mesh:

Year:  2019        PMID: 31201493     DOI: 10.1007/s00384-019-03328-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  6 in total

1.  Prognostic value of tumor deposits in locally advanced rectal cancer: a retrospective study with propensity score matching.

Authors:  Hang Zheng; Jixin Zhang; Yucun Liu; Xin Wang
Journal:  Int J Clin Oncol       Date:  2021-03-19       Impact factor: 3.402

2.  The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer.

Authors:  Mingyu Shi; Hongzhi Zhang; Guozhong Yao; Jianjun Wu; Chuming Zhu; Xu Zhang; Yuan Ren
Journal:  Front Oncol       Date:  2020-10-14       Impact factor: 6.244

3.  Tumor deposit serves as a prognostic marker in gastric cancer: A propensity score-matched analysis comparing survival outcomes.

Authors:  Liang Wenquan; Liu Yuhua; Cui Jianxin; Xi Hongqing; Zhang Kecheng; Li Jiyang; Gao Yunhe; Liu Yi; Zhang Wang; Li Shaoqing; Lu Yixun; Qiao Shen; Xue Wanguo; Qiao Zhi; Chen Lin
Journal:  Cancer Med       Date:  2020-03-12       Impact factor: 4.452

4.  The Prognostic Significance of Tumor Deposit Count for Colorectal Cancer Patients after Radical Surgery.

Authors:  Kuo Zheng; Nanxin Zheng; Cheng Xin; Leqi Zhou; Ge Sun; Rongbo Wen; Hang Zhang; Guanyu Yu; Chenguang Bai; Wei Zhang
Journal:  Gastroenterol Res Pract       Date:  2020-03-17       Impact factor: 2.260

5.  Postoperative radioiodine therapy impact on survival in poorly differentiated thyroid carcinoma: a population-based study.

Authors:  Lei Xu; Qiong Zou; Ju Jiao; Yong Zhang
Journal:  Nucl Med Commun       Date:  2022-02-01       Impact factor: 1.690

Review 6.  Beyond N staging in colorectal cancer: Current approaches and future perspectives.

Authors:  Gianluca Arrichiello; Mario Pirozzi; Bianca Arianna Facchini; Sergio Facchini; Fernando Paragliola; Valeria Nacca; Antonella Nicastro; Maria Anna Canciello; Adele Orlando; Marianna Caterino; Davide Ciardiello; Carminia Maria Della Corte; Morena Fasano; Stefania Napolitano; Teresa Troiani; Fortunato Ciardiello; Giulia Martini; Erika Martinelli
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.